Transnational Collaborative Health Tech Assessments Have Much To Offer

Joint HTA Work Could Focus on Health Economics And Real-World Evidence

European cross-border HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, say Nordic health technology assessment experts. Talks on HTA collaborations outside Europe are also underway.

Health economics and real-world evidence (RWE) are two potential areas that could benefit from greater European cross-border cooperation on health technology assessment (HTA), say experts from the Joint Nordic HTA-Bodies (JNHB). Such partnerships could extend beyond Europe.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Transnational Collaborative Health Tech Assessments Have Much To Offer

Joint HTA Work Could Focus on Health Economics And Real-World Evidence

Read the full article – start your free trial today!

More from Innovation

More from Market Access